Publications by authors named "Stephan Urwyler"

Claim this Profile
D
Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist.
David Orain, Engin Tasdelen, Samuel Haessig, Manuel Koller, Anne Picard, Stephan Urwyler

ChemMedChem· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists.
David Orain, Silvio Ofner, Manuel Koller, David A Carcache, Wolfgang Froestl, Stephan Urwyler

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity.
Manuel Koller, Kurt Lingenhoehl, Markus Schmutz, Ivan-Toma Vranesic, Joerg Kallen, Stephan Urwyler

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
Stephan Urwyler

Pharmacol Rev· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel N-methyl-D-aspartate receptor antagonists: a review of compounds patented since 2006.
Manuel Koller, Stephan Urwyler

Expert Opin Ther Pat· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complex.
Stephan Urwyler, Philipp Floersheim, Bernard L Roy, Manuel Koller

J Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-(aminomethyl)piperazine-2,5-dione as a novel NMDA glycine site inhibitor from the chemical universe database GDB.
Kong Thong Nguyen, Erika Luethi, Salahuddin Syed, Stephan Urwyler, Sonia Bertrand

Bioorg Med Chem Lett· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.
Tina Gjoni, Stephan Urwyler

Eur J Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.
Tina Gjoni, Stephan Urwyler

Neuropharmacology· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of GABAB receptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release.
Peter C Waldmeier, Klemens Kaupmann, Stephan Urwyler

J Neural Transm (Vienna)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of NMDA glycine site inhibitors from the chemical universe database GDB.
Kong Thong Nguyen, Salahuddin Syed, Stephan Urwyler, Sonia Bertrand, Daniel Bertrand

ChemMedChem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies.
Samuel Hintermann, Ivo Vranesic, Hans Allgeier, Armin Brülisauer, Daniel Hoyer, Stephan Urwyler

Bioorg Med Chem· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo.
Tina Gjoni, Sandrine Desrayaud, Stefan Imobersteg, Stephan Urwyler

J Neurochem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties.
Stephan Urwyler, Tina Gjoni, Jelena Koljatić, Delphine S Dupuis

Neuropharmacology· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors.
Stephan Urwyler, Tina Gjoni, Klemens Kaupmann, Mario F Pozza, Johannes Mosbacher

Eur J Pharmacol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.
Stephan Urwyler, Mario F Pozza, Kurt Lingenhoehl, Johannes Mosbacher, Christina Lampert

J Pharmacol Exp Ther· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival signaling and selective neuroprotection through glutamatergic transmission.
Ben A Bahr, Jennifer Bendiske, Queenie B Brown, Subramani Munirathinam, Ebru Caba, Stephan Urwyler

Exp Neurol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis